| DB ID | MyCo_4159 |
| Title | Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China |
| Year | 2020 |
| PMID | 32363569 |
| Fungal Diseases involved | Pneumocystis jirovecii pneumonia |
| Associated Medical Condition | None |
| Genus | Pneumocystis |
| Species | jirovecii |
| Organism | Pneumocystis jirovecii |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PCT (> 0.5 ng/mL ) |
| Biomarker Full Name | Procalcitonin (> 0.5 ng/mL ) |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | China |
| Cohort | From January 2015 to June 2019, a total of 96 hospitalized patients were found to have PJP based on our screening criteria. |
| Cohort No. | 96 |
| Age Group | None |
| P Value | p= 0.64 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Immunological Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunological Assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
